Showing 2361-2370 of 2527 results for "".
- Zeiss Ranked Best Company in Germany’s Public Value Atlashttps://modernod.com/news/zeiss-ranked-best-company-in-germanys-public-value-atlas/2476600/Zeiss is Germany’s highest-ranked company in the 2019 Public Value Atlas (Gemeinwohlatlas 2019). The announcement was made in Berlin by the authors of the study, the Center for Leadership and Values in Society at the University of St. Gallen (CLVS-HSG) in cooperation with the Dr. Arend Oetk
- Surgical Specialties Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedureshttps://modernod.com/news/surgical-specialties-launches-caliber-ophthalmics-division-to-focus-on-global-growth-of-ophthalmic-surgical-procedures/2476597/Surgical Specialties Corporation (SSC) announced the launch of Caliber Ophthalmics, a new business division that combines SSC’s Sharpoint brand with its two recent ophthalmic acquisitions, Unique Technologies and VPM Surgical. To lead the Caliber Ophthalmics division, SSC has named <
- Jefferson and Wills Eye Launch World’s First Center Focused on Connections Between the Eye and the Brainhttps://modernod.com/news/jefferson-and-wills-eye-launch-worlds-first-center-focused-on-connections-between-the-eye-and-the-brain/2476574/Thomas Jefferson University, in partnership with Wills Eye Hospital and thanks to the generosity of several prescient philanthropists, has launched the world’s first center focused on the visual signatures of neurological diseases. The William H. Annesley, Jr., MD ’48 EyeBrain Center will explore
- Drusen Characteristics Linked With AMD Risk in Fellow Eyeshttps://modernod.com/news/drusen-characteristics-linked-with-amd-risk-in-fellow-eyes/2476571/In patients with unilateral neovascular age-related macular degeneration (AMD), certain drusen features are associated with conversion to neovascular AMD in the fellow eye, according to a secondary analysis of data from a clinical trial, as re
- Watchful Waiting OK in Diabetic Macular Edema With Good Visionhttps://modernod.com/news/watchful-waiting-ok-in-diabetic-macular-edema-with-good-vision/2476573/Among patients with center-involved diabetic macular edema (DME) who had good visual acuity, there were no significant differences in vision loss over a 2-year period for those who were initially managed with watchful waiting as compared with those who underwent treatment with laser photocoagulat
- Novartis to Acquire Dry Eye Drug Xiidra in Deal Worth Up to $5.3 Billionhttps://modernod.com/news/novartis-to-acquire-dry-eye-drug-xiidra-in-deal-worth-up-to-5-3-billion/2476567/In one of the largest ophthalmic drug deals to date, Novartis has agreed to acquire dry eye drug Xiidra (lifitegrast ophthalmic solution) 5% from Takeda Pharmaceutical in a deal worth up to $5.3 billion. Under terms of the deal, Novartis will pay $3.4 billi
- IBM’s New AI Technique Could Detect Glaucoma Earlierhttps://modernod.com/news/ibms-new-ai-technique-could-detect-glaucoma-earlier/2476530/At ARVO, IBM researchers presented new techniques in deep learning that could help unlock earlier glaucoma detection. IBM and NYU’s research demonstrates how deep learning models can be trained to learn from and analyze easily-obtained retina images, and then use this analysis to directly estimat
- Implandata Gains CE Mark for its Eyemate System for Keratoprosthesishttps://modernod.com/news/implandata-gains-ce-mark-for-its-eyemate-system-for-keratoprosthesis/2476510/Ophthalmic sensors and digital health company Implandata Ophthalmic Products announced that it attained CE mark for its Eyemate system for use in patients undergoing keratoprosthesis surgery. Keratoprosthesis represents an infrequent yet important procedure for restoring vision. It is performed o
- ProtoKinetix AAGP in Phase 3 Retinal Replacement Programhttps://modernod.com/news/protokinetix-aagp-in-phase-3-retinal-replacement-program/2476493/ProtoKinetix updated its stockholders regarding phase 3 of testing using AAGP in retinal cell replacement therapy at the University of British Columbia. The study is now using 2 animal models and a significantly larger number of animals in both control and AAGP treated groups for a longer
- Bausch + Lomb Announces New Divisional Leadership in the UShttps://modernod.com/news/bausch-lomb-announces-new-divisional-leadership-in-the-us/2476487/Bausch + Lomb announced the appointment of new leadership in its Pharmaceuticals and Consumer Health Care divisions in the United States. Yolande Barnard, formerly the vice president, marketing and sales, U.S. Neurology, Bausch Health, will now serve as vice president and general manager,